Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy
Reading Time: < 1 minute
Topic: Oncology
LC-MS determination of Nicotiana benthamiana host plant proteins in the drug products of recombinant plant-produced pembrolizumab
Reading Time: < 1 minute
Development of Plant-Derived Bispecific Monoclonal Antibody Targeting PD-L1 and CTLA-4 against Mouse Colorectal Cancer
Reading Time: < 1 minute
Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL/6-hPD-1 mouse implanted with MC38 colon cancer
Reading Time: < 1 minute
Plant-derived Pembrolizumab in conjugation with IL-15Rα-IL-15 complex shows effective anti-tumor activity
Reading Time: < 1 minute
Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
Reading Time: < 1 minute
Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
Reading Time: < 1 minute
Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
Reading Time: < 1 minute
Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
Reading Time: < 1 minute
Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice
Reading Time: < 1 minute